collection
MENU ▼
Read by QxMD icon Read
search

Hypertension

shared collection
6 papers 1000+ followers
By Ana Monteiro Md/phd student
https://www.readbyqxmd.com/read/24245566/stenting-and-medical-therapy-for-atherosclerotic-renal-artery-stenosis
#1
RANDOMIZED CONTROLLED TRIAL
Christopher J Cooper, Timothy P Murphy, Donald E Cutlip, Kenneth Jamerson, William Henrich, Diane M Reid, David J Cohen, Alan H Matsumoto, Michael Steffes, Michael R Jaff, Martin R Prince, Eldrin F Lewis, Katherine R Tuttle, Joseph I Shapiro, John H Rundback, Joseph M Massaro, Ralph B D'Agostino, Lance D Dworkin
BACKGROUND: Atherosclerotic renal-artery stenosis is a common problem in the elderly. Despite two randomized trials that did not show a benefit of renal-artery stenting with respect to kidney function, the usefulness of stenting for the prevention of major adverse renal and cardiovascular events is uncertain. METHODS: We randomly assigned 947 participants who had atherosclerotic renal-artery stenosis and either systolic hypertension while taking two or more antihypertensive drugs or chronic kidney disease to medical therapy plus renal-artery stenting or medical therapy alone...
January 2, 2014: New England Journal of Medicine
https://www.readbyqxmd.com/read/24352797/2014-evidence-based-guideline-for-the-management-of-high-blood-pressure-in-adults-report-from-the-panel-members-appointed-to-the-eighth-joint-national-committee-jnc-8
#2
Paul A James, Suzanne Oparil, Barry L Carter, William C Cushman, Cheryl Dennison-Himmelfarb, Joel Handler, Daniel T Lackland, Michael L LeFevre, Thomas D MacKenzie, Olugbenga Ogedegbe, Sidney C Smith, Laura P Svetkey, Sandra J Taler, Raymond R Townsend, Jackson T Wright, Andrew S Narva, Eduardo Ortiz
Hypertension is the most common condition seen in primary care and leads to myocardial infarction, stroke, renal failure, and death if not detected early and treated appropriately. Patients want to be assured that blood pressure (BP) treatment will reduce their disease burden, while clinicians want guidance on hypertension management using the best scientific evidence. This report takes a rigorous, evidence-based approach to recommend treatment thresholds, goals, and medications in the management of hypertension in adults...
February 5, 2014: JAMA: the Journal of the American Medical Association
https://www.readbyqxmd.com/read/11833827/a-multicenter-randomized-double-blind-comparison-of-the-efficacy-and-safety-of-irbesartan-and-enalapril-in-adults-with-mild-to-moderate-essential-hypertension-as-assessed-by-ambulatory-blood-pressure-monitoring-the-mapavel-study-monitorizaci%C3%A3-n-ambulatoria
#3
RANDOMIZED CONTROLLED TRIAL
Antonio Coca, Carlos Calvo, Juan García-Puig, Blas Gil-Extremera, Maria T Aguilera, Alejandro de la Sierra, Alberto Martín-Hidalgo, Rafael Marín
BACKGROUND: When blood pressure (BP)-lowering efficacy is assessed by measurements taken in a clinic setting, angiotensin II-receptor antagonists show similar efficacy to angiotensin-converting enzyme inhibitors and better tolerability. A search of MEDLINE to date, however, reveals no randomized, double-blind studies using ambulatory BP monitoring (ABPM) to compare the BP-lowering efficacy of irbesartan and enalapril in a large number of patients ( > 200) with essential hypertension...
January 2002: Clinical Therapeutics
https://www.readbyqxmd.com/read/16060413/effect-of-irbesartan-monotherapy-compared-with-ace-inhibitors-and-calcium-channel-blockers-on-patient-compliance-in-essential-hypertension-patients-a-multicenter-open-labeled-three-armed-study
#4
MULTICENTER STUDY
Nevres Koylan, Esmeray Acarturk, Aykan Canberk, Nail Caglar, Sali Caglar, Serap Erdine, Sema Guneri, Baris Ilerigelen, Giray Kabakci, Remzi Onder, Olcay Sagkan, Kemalettin Buyukozturk
OBJECTIVES: This multicenter, three-armed, open-labeled study investigated patient compliance of patients receiving irbesartan, angiotensin-converting enzyme (ACE) inhibitors or calcium-channel blockers (CCB) for essential hypertension for a 6-month period. Patients were either newly diagnosed or switched from existing antihypertensive medication due to lack of efficacy or side-effects. METHODS: Patients were started monotherapy with irbesartan (n=377), ACE inhibitors (n=298) or CCB (n=308) and were reevaluated on 1st, 3rd, and 6th months of the treatment...
July 2005: Blood Pressure. Supplement
https://www.readbyqxmd.com/read/23585649/a-review-of-the-use-of-angiotensin-receptor-blockers-for-the-prevention-of-cardiovascular-events-in-patients-with-essential-hypertension-without-compelling-indications
#5
REVIEW
Kathy Zaiken, Timothy R Hudd, Judy W M Cheng
OBJECTIVE: To review the role of angiotensin receptor blockers (ARBs) for the prevention of cardiovascular events in patients with essential hypertension without other compelling indications. DATA SOURCES: Peer-reviewed clinical trials, review articles, and relevant treatment guidelines were identified from MEDLINE and Current Content database (both 1966-November 15, 2012) using the search terms angiotensin receptor blockers (ARBs), azilsartan, candesartan, eprosartan, irbesartan, losartan, olmesartan, telmisartan, valsartan, hypertension, myocardial infarction, stroke, heart failure, and cardiovascular outcomes...
May 2013: Annals of Pharmacotherapy
https://www.readbyqxmd.com/read/22147122/updated-report-on-comparative-effectiveness-of-ace-inhibitors-arbs-and-direct-renin-inhibitors-for-patients-with-essential-hypertension-much-more-data-little-new-information
#6
REVIEW
Benjamin J Powers, Remy R Coeytaux, Rowena J Dolor, Vic Hasselblad, Uptal D Patel, William S Yancy, Rebecca N Gray, R Julian Irvine, Amy S Kendrick, Gillian D Sanders
OBJECTIVES: A 2007 systematic review compared angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) in patients with hypertension. Direct renin inhibitors (DRIs) have since been introduced, and significant new research has been published. We sought to update and expand the 2007 review. DATA SOURCES: We searched MEDLINE and EMBASE (through December 2010) and selected other sources for relevant English-language trials. STUDY ELIGIBILITY CRITERIA, PARTICIPANTS, AND INTERVENTIONS: We included studies that directly compared ACE inhibitors, ARBs, and/or DRIs in at least 20 total adults with essential hypertension; had at least 12 weeks of follow-up; and reported at least one outcome of interest...
June 2012: Journal of General Internal Medicine
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"